Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation
- PMID: 16504888
- DOI: 10.1016/j.gassur.2005.06.019
Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation
Abstract
We report a case of a patient with end-stage liver disease secondary to hepatitis C, complicated by a large hepatocellular carcinoma. Because of the size of the tumor exceeded the Milan criteria, he was not a candidate for liver transplantation. However, after two treatments with yttrium-90 glass microsphere infusions, the tumor became smaller and the patient's alpha-fetoprotein level dropped to normal range. He was listed for transplantation and subsequently received a deceased donor liver transplant. Two years after his transplantation, he remains tumor free and has normal alpha-fetoprotein levels. This is the first reported case in the literature of using yttrium-90 microspheres as a bridge to liver transplantation in a patient with a large hepatocellular carcinoma. This therapy should be considered in patients with cirrhosis and large hepatocellular carcinomas exceeding current size criterion, who would otherwise be good candidates for transplantation.
Similar articles
-
Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.Transplant Proc. 2010 Apr;42(3):994-8. doi: 10.1016/j.transproceed.2010.03.019. Transplant Proc. 2010. PMID: 20430224
-
Downstaging of bilobar hepatocellular carcinoma after radioembolization with 90Y microspheres as a bridge to liver transplantation.Rev Esp Med Nucl Imagen Mol. 2017 Sep-Oct;36(5):329-332. doi: 10.1016/j.remn.2016.12.006. Epub 2017 Mar 6. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 28268101 English, Spanish.
-
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.Eur J Surg Oncol. 2012 Jul;38(7):594-601. doi: 10.1016/j.ejso.2012.02.189. Epub 2012 Mar 21. Eur J Surg Oncol. 2012. PMID: 22440743
-
(90)Y-glass microspheres for hepatic neoplasia.Future Oncol. 2015;11(9):1343-54. doi: 10.2217/fon.15.12. Future Oncol. 2015. PMID: 25952780 Review.
-
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1552-63. doi: 10.1016/j.ijrobp.2004.09.004. Int J Radiat Oncol Biol Phys. 2004. PMID: 15590187 Review.
Cited by
-
Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review.Transl Gastroenterol Hepatol. 2017 Nov 27;2:98. doi: 10.21037/tgh.2017.11.11. eCollection 2017. Transl Gastroenterol Hepatol. 2017. PMID: 29264436 Free PMC article. Review.
-
Radioembolization of yttrium-90 microspheres for hepatic malignancy.Semin Intervent Radiol. 2008 Mar;25(1):48-57. doi: 10.1055/s-2008-1052306. Semin Intervent Radiol. 2008. PMID: 21326493 Free PMC article.
-
Trans-arterial hepatic radioembolisation of yttrium-90 microspheres.Biomed Imaging Interv J. 2006 Jul;2(3):e43. doi: 10.2349/biij.2.3.e43. Epub 2006 Jul 1. Biomed Imaging Interv J. 2006. PMID: 21614250 Free PMC article.
-
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.World J Surg. 2017 Jan;41(1):241-249. doi: 10.1007/s00268-016-3682-z. World J Surg. 2017. PMID: 27495316
-
[Tumor and transplantation].Chirurg. 2013 Aug;84(8):690-7. doi: 10.1007/s00104-012-2426-3. Chirurg. 2013. PMID: 23831889 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical